DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Restasis (Cyclosporine Ophthalmic) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

RESTASIS SUMMARY

RESTASIS®
(cyclosporine ophthalmic emulsion) 0.05%

RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% contains a topical immunomodulator with anti-inflammatory effects.

RESTASIS® ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs.


See all Restasis indications & dosage >>

RESTASIS NEWS HIGHLIGHTS

Published Studies Related to Restasis (Cyclosporine Ophthalmic)

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome. [2008.11]

Dosing and safety of cyclosporine in patients with severe brain injury. [2008.10]

Effect of cyclosporine on reperfusion injury in acute myocardial infarction. [2008.07.31]

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome. [2008.07.12]

CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A. [2008.06]

more >>

Clinical Trials Related to Restasis (Cyclosporine Ophthalmic)

Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery? [Completed]

Metabolic Pattern of Cyclosporine A and Acute Renal Failure [Completed]

Maintenance Neoral Monotherapy Compared to Bitherapy in Renal Transplantation [Completed]

Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels [Active, not recruiting]

The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients [Active, not recruiting]

more >>

RESTASIS PATIENT REVIEWS / RATINGS / COMMENTS

Based on a total of 2 ratings/reviews, Restasis has an overall score of 9.50. The effectiveness score is 9 and the side effect score is 9. The scores are on ten point scale: 10 - best, 1 - worst.
 

Restasis review by medical professional caring for 45 year old female patient

  Rating
Overall rating:  
Effectiveness:   Highly Effective
Side effects:   Mild Side Effects
  
Treatment Info
Condition / reason:   dry eyes
Dosage & duration:   0.05 % twice a day (dosage frequency: 6 months) for the period of 6 months
Other conditions:   blepharitis
Other drugs taken:   none
  
Reported Results
Benefits:   Restasis helps with tear related problems: dryness, reflex overtearing, mucous discharge, irritated eyes, redness and lid swelling. It can irritate at the initial time of therapy but with extra artificial tears this effect is lessoned.
Side effects:   some people get prolonged stinging for 5 to 10 minutes and occasionally increased redness and lid swelling
Comments:   maintainence for chronic dry eye and sometimes helpful for blepharitis as well.

 

Restasis review by 40 year old female patient

  Rating
Overall rating:  
Effectiveness:   Considerably Effective
Side effects:   No Side Effects
  
Treatment Info
Condition / reason:   chronic dry eyes
Dosage & duration:   2 drops each eye BID (dosage frequency: bid) for the period of 2 years
Other conditions:   none
Other drugs taken:   Zovia
  
Reported Results
Benefits:   significantly improved dryness of eyes
Side effects:   none
Comments:   Have had chronically dry eyes for years. Regular eye drops helped temporarily (but blurred vision). Also had Herrick plugs, which seemded to help for awhile. Then doc finally recommended Restasis, and eyes have become much less dry. Very pleased with the results of the treatment.

See all Restasis reviews / ratings >>

Page last updated: 2008-11-03

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008